相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。TSC2 regulates microRNA biogenesis via mTORC1 and GSK3β
Barbara Ogorek et al.
HUMAN MOLECULAR GENETICS (2018)
Human renal angiomyolipoma cells of male and female origin can migrate and are influenced by microenvironmental factors
Francesca Bertolini et al.
PLOS ONE (2018)
TSC1 and TSC2 gene mutations and their implications for treatment in Tuberous Sclerosis Complex: a review
Clevia Rosset et al.
GENETICS AND MOLECULAR BIOLOGY (2017)
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rajesha Rupaimoole et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
mTORC1 signaling and the metabolic control of cell growth
Issam Ben-Sahra et al.
CURRENT OPINION IN CELL BIOLOGY (2017)
Tuberous sclerosis complex
Elizabeth P. Henske et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
The Emerging Role of Inhibitor of Growth 4 as a Tumor Suppressor in Multiple Human Cancers
Shiyun Cui et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
An mTORC1-Mdm2-Drosha Axis for miRNA Biogenesis in Response to Glucose- and Amino Acid-Deprivation
Peiying Ye et al.
MOLECULAR CELL (2015)
Prognostic significance of KAI1/CD82 in human melanoma and its role in cell migration and invasion through the regulation of ING4
Yun Tang et al.
CARCINOGENESIS (2014)
The role, mechanism and potentially therapeutic application of microRNA-29 family in acute myeloid leukemia
J-N Gong et al.
CELL DEATH AND DIFFERENTIATION (2014)
Comprehensive molecular characterization of urothelial bladder carcinoma
John N. Weinstein et al.
NATURE (2014)
Inhibitor of growth 4 induces NFκB/p65 ubiquitin-dependent degradation
Y. Hou et al.
ONCOGENE (2014)
Diverse roles of miR-29 in cancer (Review)
Hesong Jiang et al.
ONCOLOGY REPORTS (2014)
Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma
T. Kinoshita et al.
BRITISH JOURNAL OF CANCER (2013)
miR-29b negatively regulates human osteoclastic cell differentiation and function: Implications for the treatment of multiple myeloma-related bone disease
Marco Rossi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Effect of miR-29b-1*and miR-29c knockdown on cell growth of the bladder cancer cell line T24
Feng Xu et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2013)
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
David Neal Franz et al.
LANCET (2013)
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
John J. Bissler et al.
LANCET (2013)
Comprehensivemolecular characterization of clear cell renal cell carcinoma
Chad J. Creighton et al.
NATURE (2013)
MicroRNA-21 is Induced by Rapamycin in a Model of Tuberous Sclerosis (TSC) and Lymphangioleiomyomatosis (LAM)
Anil J. Trindade et al.
PLOS ONE (2013)
A Key Role of microRNA-29b for the Suppression of Colon Cancer Cell Migration by American Ginseng
Deepak Poudyal et al.
PLOS ONE (2013)
An Extensive Network of TET2-Targeting MicroRNAs Regulates Malignant Hematopoiesis
Jijun Cheng et al.
CELL REPORTS (2013)
Serum VEGF-D concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial
Lisa R. Young et al.
LANCET RESPIRATORY MEDICINE (2013)
Lymphangioleiomyomatosis Calling It What It Is: A Low-Grade, Destructive, Metastasizing Neoplasm
Francis X. McCormack et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
A combined approach identifies three mRNAs that are down-regulated by microRNA-29b and promote invasion ability in the breast cancer cell line MCF-7
Chen Wang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
miRNA-29b Suppresses Prostate Cancer Metastasis by Regulating Epithelial-Mesenchymal Transition Signaling
Peng Ru et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Negative Regulation of NF-κB by the ING4 Tumor Suppressor in Breast Cancer
Sara A. Byron et al.
PLOS ONE (2012)
miR-29b regulates migration of human breast cancer cells
Chen Wang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
An Atlas of Combinatorial Transcriptional Regulation in Mouse and Man
Timothy Ravasi et al.
CELL (2010)
Transcriptional Suppression of mir-29b-1/mir-29a Promoter by c-Myc, Hedgehog, and NF-kappaB
Justin L. Mott et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2010)
Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis.
Darcy A. Krueger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1
Ramiro Garzon et al.
BLOOD (2009)
miR-29 miRNAs activate p53 by targeting p85a and CDC42
Seong-Yeon Park et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Role of ING4 in human melanoma cell migration, invasion and patient survival
Jun Li et al.
CARCINOGENESIS (2008)
Molecular basis of histone H3K4me3 recognition by ING4
Alicia Palacios et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis
John J. Bissler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B
Muller Fabbri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
mir-29 regulates Mcl-1 protein expression and apoptosis
J. L. Mott et al.
ONCOGENE (2007)
Inhibitor of growth 4 suppresses cell spreading and cell migration by interacting with a novel binding partner, liprin α1
Jiang-Cheng Shen et al.
CANCER RESEARCH (2007)
ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation
Y Doyon et al.
MOLECULAR CELL (2006)
Induction of cyclooxygenase-2 by benzo[a]pyrene diol epoxide through inhibition of retinoic acid receptor-β2 expression
SM Song et al.
ONCOGENE (2005)
Impaired retinoic acid (RA) signal leads to RARβ2 epigenetic silencing and RA resistance
MQ Ren et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Metastasis of benign tumor cells in tuberous sclerosis complex
EP Henske
GENES CHROMOSOMES & CANCER (2003)
Molecular genetic advances in tuberous sclerosis
JP Cheadle et al.
HUMAN GENETICS (2000)
Evidence that retinoic acid receptor β induction by retinoids is important for tumor cell growth inhibition
SY Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis
T Carsillo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
